NCT00522470View on ClinicalTrials.gov

Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels

PHASE4CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Type 2 Diabetes MellitusObesity

Interventions

DRUG

rosiglitazone

Trial Locations (1)

06490

Baskent University Hospital Department of Endocrinology, Ankara

All Listed Sponsors

lead

Baskent University

OTHER